Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03215810
Title Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

tumor infiltrating lymphocytes

Cyclophosphamide + Fludarabine

Aldesleukin

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Florida Health Cancer Center. Gainesville Florida 32608 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field